B
AZN icon

BP’s AstraZeneca AZN Stock Holding History

BP’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-211,207
Closed -$25.3M – 57
2021
Q2 		$25.3M Sell
211,207
-70,636
-25% -$7.75M 1.08% 14
2021
Q1 		$28M Sell
281,843
-71,789
-20% -$7.22M 0.98% 16
2020
Q4 		$35.3M Buy
353,632
+48,302
+16% +$5.12M 1.07% 20
2020
Q3 		$33.5M Buy
+305,330
New +$34M 0.81% 21

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BP's AZN Position: Q3 2021 in Review

BP sold out of AstraZeneca (AZN) in Q3 2021, closing a stake of 211,207 shares — an estimated $25.3M sold.

BP first reported a position in AZN in Q3 2020 and held it in 4 quarters. The position peaked at $35.3M in Q4 2020. 908 funds tracked by Wall St. Rank hold AZN as of Q3 2021.

  • BP reported no remaining AstraZeneca position as of Q3 2021 after selling out during the quarter.
  • BP sold 211,207 AstraZeneca shares in Q3 2021, an estimated $25.3M.
  • BP first reported a position in AstraZeneca in Q3 2020 and held it in 4 quarters.
  • BP's AstraZeneca position peaked at $35.3M in Q4 2020.
  • 908 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2021.

Based on BP's 13F filing for Q3 2021, filed 10 Nov 2021.